Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0VNMKF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Antibody-drug conjugate (Novartis/ImmunoGen)
|
|||||
| Synonyms |
Antibody-drug conjugate (Novartis/ImmunoGen)
Click to Show/Hide
|
|||||
| Organization |
Novartis Institutes for Biomedical Research, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 5 Indication(s)
Acute granulocytic leukaemia [ICD11:2B33]
Clinical candidate
Gastrointestinal interstitial cancer [ICD11:2B5B]
Clinical candidate
Melanoma [ICD11:2C30]
Clinical candidate
Non-small cell lung cancer [ICD11:2C25]
Clinical candidate
Small cell lung cancer [ICD11:2C25]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Cadherin-3 (CDH3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.